ASTEPRO® ALLERGY ANTIHISTAMINE NASAL SPRAY

ASTEPRO® ALLERGY ANTIHISTAMINE NASAL SPRAY

Astepro allergy is now approved. Previously only available as Rx. The first1 and only2 OTC antihistamine nasal spray3 




References:

  1. FDA approves a nasal antihistamine for nonprescription use. Approval is a first-in-class and was enabled by the prescription to nonprescription switch process. News release. FDA; June 17, 2021. Accessed March 2, 2022. https://www.fda.gov/news-events/press-announcements/fda-approves-nasal-antihistamine-nonprescription-use.  

  2. Data on file. Bayer. IRI data. Only OTC AH. 

  3. NDA 213872.

  4. Stewart M, Ferguson BJ, Fromer L. Epidemiology and burden of nasal congestion. Int J Gen Med. 2010;3:37-45. 

  5. Data on file. Bayer. MP440 CSR. Symptom scores. 

  6. van Bavel J, Howland WC, Amar NJ, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(5):512-518.

  7. Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(6):628-633. doi:10.2500/aap.2009.30.3296 

  8. Howland WC, Amar NJ, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen. Int Forum Allergy Rhinol. 2011;1(4):275-279. doi:10.1002/alr.20065 

  9. Astepro®. Prescribing information. Meda Pharmaceuticals Inc; 2018. 

  10. US Department of Health and Human Services. Pediatric Postmarketing Pharmacovigilance and Drug Utilization Review. November 3, 2016. Accessed April 7, 2022. https://www.fda.gov/media/100100/download. 

  11. Astelin. Prescribing information. Meda Pharmaceuticals Inc; 2014. 

  12. Watts AM, Cripps AW, West NP, Cox AJ. Modulation of allergic inflammation in the nasal mucosa of allergic rhinitis sufferers with topical pharmaceutical agents. Front Pharmacol. 2019;10:294:1-22. doi:10.3389/fphar.2019.00294  

  13. Flonase® Drug Facts Label. NDA205434.  

  14. Nasacort® Drug Facts Label. NDA020468. 

  15. Rhinocort® Drug Facts Label. NDA020746.